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ABSTRACT Neurotensin receptor 1 (NTS1), a Family A G-protein coupled receptor (GPCR), was expressed in Escherichia coli
as a fusion with the ﬂuorescent proteins eCFP or eYFP. A ﬂuorophore-tagged receptor was used to study the multimerization of
NTS1 in detergent solution and in brain polar lipid bilayers, using ﬂuorescence resonance energy transfer (FRET). A detergent-
solubilized receptor was unable to form FRET-competent complexes at concentrations of up to 200 nM, suggesting that the
receptor is monomeric in this environment. When reconstituted into a model membrane system at low receptor density, the
observed FRET was independent of agonist binding, suggesting constitutive multimer formation. In competition studies,
decreased FRET in the presence of untagged NTS1 excludes the possibility of ﬂuorescent protein-induced interactions. A simu-
lation of the experimental data indicates that NTS1 exists predominantly as a homodimer, rather than as higher-order multimers.
These observations suggest that, in common with several other Family A GPCRs, NTS1 forms a constitutive dimer in lipid bila-
yers, stabilized through receptor-receptor interactions in the absence of other cellular signaling components. Therefore, this work
demonstrates that well-characterized model membrane systems are useful tools for the study of GPCRmultimerization, allowing
ﬁne control over system composition and complexity, provided that rigorous control experiments are performed.INTRODUCTION
G-protein coupled receptors (GPCRs), of which more than
750 have been identified in the human genome (1), are
a family of integral membrane proteins with seven trans-
membrane helices. GPCRs are involved in a wide range of
physiological processes, including cell-cell communication,
sensory transduction, neuronal transmission, and hormonal
signaling (2,3), and are consequently of particular pharmaco-
logical importance (4).
Neurotensin (NT) is an endogenous tridecapeptide
neurotransmitter (N-Glu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-
Pro-Tyr-Ile-Leu-C), found in mammalian gastrointestinal,
cardiovascular, and central nervous systems, that is respon-
sible for the activation of the neurotensin receptor (NTS)
family (5). One such receptor, neurotensin receptor type 1
(NTS1), binds NT with high affinity (Kd ¼ 1 nM), and is
a member of the GPCR superfamily (6).
The suggestion that GPCRs function as isolated mono-
meric receptors in the cell membrane has been challenged
by results consistent with GPCRs functioning as dimers or
higher-order oligomers, and the subject was recently
reviewed in detail (7–10). GPCR multimerization is thought
to have important functional implications, including cell-
surface expression, ligand binding, signaling, and receptor
trafficking (8). Although the concept of multimerization is
widely accepted, considerable variation exists between
reports of the effects of agonist ligands on the multimeriza-
tion state. There are some examples of agonist-mediated
multimerization, e.g., as described for purified leukotriene
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described in an initial study of the d-opioid receptor (12).
However, constitutive multimerization has been most widely
reported.
GPCR multimerization was demonstrated for numerous
receptor types using biochemical approaches, including co-
immunoprecipitation (13) and functional complementation
(14,15). Resonance energy transfer (RET) techniques, such
as fluorescence resonance energy transfer (FRET) and biolu-
minescence resonance energy transfer (BRET), were used to
probe GPCR multimerization in vivo (16,17). However,
some criticism of the methodologies used to demonstrate
multimerization has been made, including the possibility of
nonspecific aggregation, incomplete solubilization, or insuf-
ficient centrifugation during immunoprecipitation proce-
dures (9). In addition, a study involving the rigorous
treatment of BRET data suggested that the multimerization
of GPCRs may not be as prevalent as previously reported
using RET techniques, because of the underestimation of
energy transfer caused by random interactions of receptors
in the membrane environment (16). This serves to highlight
that the extent of GPCRmultimerization is by no means fully
understood. There are, to the best of our knowledge, no pub-
lished data regarding NTS1 homomultimerization in the lipid
membrane environment. Immunoprecipitation studies sug-
gested possible heterodimerization with other members of
the NTS family (18,19), and one study indirectly revealed
NTS1 monomers and dimers in detergent solution under
certain conditions (20).
The majority of GPCR multimerization studies to date
have been performed in transfected cell lines (10). The study
of GPCR multimerization, using well-characterized in vitro
doi: 10.1016/j.bpj.2008.09.054
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mechanism of multimerization, while maintaining fine
control of system conditions and components. Such fine
control over system parameters, including receptor density,
lipid composition, and donor/acceptor ratio, is of particular
advantage, given the multitude of controls considered neces-
sary to confirm that an observed RET arises from true
receptor-receptor interactions (16). Indeed, a recent FRET
study of rhodopsin photoreceptors reconstituted into asolec-
tin liposomes revealed receptor self-association (21).
Here, purified NTS1 receptor, tagged with enhanced cyan
fluorescent protein (eCFP) and enhanced yellow fluorescent
protein (eYFP), is used to develop an in vitro system for the
study of the NTS1 multimerization state in lipid bilayers.
This FRET study of eCFP-tagged and eYFP-tagged NTS1,
reconstituted into brain polar lipid liposomes at low receptor
density, provides evidence that NTS1 receptors constitu-
tively self-associate in the membrane environment in an
agonist-independent manner.
MATERIALS AND METHODS
Reconstitution of T43NTS1, T43NTS1-eCFP,
and T43NTS1-eYFP
TheN-terminally truncatedNTS1 (T43NTS1) (22–24), T43NTS1-eCFP, and
T43NTS1-eYFP (24) (Fig. 1 A) were expressed, detergent-solubilized, and
purified as described (see the Supporting Material). Purified T43NTS1,
T43NTS1-eCFP, and T43NTS1-eYFP receptors, mixed to the desired ratios,
were added to disrupted brain polar lipid (BPL) vesicles (prepared as described
in the Supporting Material), and samples were incubated for 1 h at 4C. Pre-
washed Biobeads (SM-2, Biorad, Hemel Hempstead, UK) were added to
a concentration of 120 mg/mL, and samples were incubated at 4C overnight
with gentle agitation. The Biobeads were removed, and the proteoliposomes
were isolated by sucrose density gradient centrifugation (5–35% sucrose in
50 mM Tris, pH 7.4, 200 mM NaCl, and 1 mM EDTA; 100,000  g; 4C;
15 h). Receptor density was derived by measurement of the position of recon-
stituted bands on the sucrose gradient (see the Supporting Material).
Fluorescence measurements
All FRET experiments were performed using an LS-55 Spectrofluorimeter
(Perkin Elmer, Fremont, CA) and a 1.5-mL quartz microcuvette (Hellma,
Southend-on-Sea, UK) with a magnetic stir bar. The cuvette was maintained
at a constant temperature throughout, using a recirculating water-chiller set at
4C. Excitation and emission slits were both set to a 2.5-nm bandpass. Before
the fluorescence measurements, receptor samples were diluted to the stated
receptor concentrations, using 50 mM Tris (pH 7.4), 15% glycerol (v/v),
200 mM NaCl, 0.1% dodecyl-b-D-maltoside (DDM) (w/v), 0.01% choles-
teryl hemisuccinate (CHS) (w/v), and 1 mM EDTA for detergent samples,
and 50 mM Tris (pH 7.4), 200 mMNaCl, and 1 mM EDTA for reconstituted
samples. To assess the effect of neurotensin peptide (NT) onmultimerization,
an appropriate volumeofNT stock solution (3.5mM)was added, and samples
were allowed to equilibrate for 15 min before measurement. All fluorescence
spectra were recorded in triplicate and averaged.
The FRET protocol was a variation of that proposed previously (17),
where FRET is quantified by monitoring enhanced acceptor emission
(‘‘sensitized emission’’). In each FRET experiment, fluorescence emission
spectra are recorded from four separate samples: 1), a buffer-only blank;
2), a sample containing only NTS1-eCFP; 3), a sample containing only
NTS1-eYFP; and 4), a sample containing both NTS1-eCFP and NTS1-eYFP. Fluorescence emission, because of FRET between eCFP-tagged
and eYFP-tagged receptors, was detected by using a procedure to remove
contributions of background signal, eCFP emission (‘‘bleed-through’’),
and direct eYFP emission (‘‘cross talk’’) from the eCFP-tagged and
eYFP-tagged sample emission spectrum. This was achieved as follows:
1. Subtraction of background fluorescence: Emission spectra for all samples
were recorded between 450–600 nm, using an excitation wavelength of
FIGURE 1 Analysis of an example of purification of T43NTS1-eCFP. (A)
Schematic depiction of untagged NTS1B construct (22) and fluorescence-
tagged NTS1C and NTS1Y constructs. Genes for eCFP and eYFP were
introduced into the NTS1B construct, to yield NTS1C and NTS1Y
constructs. The TeV protease cleavage sites present between the E. coli
maltose-binding protein (MBP) and T43NTS1 moieties and the eCFP/
eYFP and E. coli thioredoxin (TrxA) moieties facilitate proteolytic removal
of the fusion partners (T43NTS1, N-terminally truncated NTS1; His10,
deca-histidine tag). (B) SDS-PAGE analysis of purification, showing how
overexpression and purification were monitored using in-gel fluorescence.
Indicated fractions from T43NTS1-eCFP purification of an E. coli
C41(DE3) culture were separated on a 12% SDS-PAGE gel. In-gel fluores-
cence (bottom) was monitored, and the gel was subsequently stained with
Coomassie brilliant blue (top). The NTS1C protein is evident in the solubi-
lized and immobilized metal affinity chromatography (IMAC) elution
samples (theoretical molecular mass, 130 kDa). In post-TeV cleavage, GF
load, and gel filtration (GF) eluate lanes, the T43NTS1-eCFP cleavage
product (theoretical molecular mass, 69.9 kDa) is evident (31,32).Biophysical Journal 96(3) 964–973
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CFP), and between 520–600 nm, using an excitation wave-
length of 510 nm (lmax
YFP). The background emission obtained from
sample 1 was then subtracted from samples 2–4 for both emission
spectra.
2. Subtraction of ‘‘bleed-through’’: The emission spectrum obtained from
the excitation of sample 2 at lmax
CFP was normalized to give an eCFP
emission peak value identical to the eCFP emission peak value of sample
4. After normalization, the eCFP spectrum of sample 2 was subtracted
from the emission spectrum of sample 4. This resulted in an eYFP emis-
sion spectrum composed of a FRET component and a ‘‘cross talk’’
component because of direct excitation of eYFP, which can also be
termed the ‘‘extracted acceptor spectrum’’.
3. Subtraction of ‘‘cross talk’’: The emission spectra yielded from the exci-
tation of samples 3 and 4 at lmax
YFP were used to quantify the amount of
eYFP-tagged receptor present in each sample. This is possible because
eCFP is not excited at this wavelength. The ratio of the eYFP emission
peak heights of these two spectra were used as a scaling factor to
normalize the emission spectrum obtained when sample 3 was irradiated
at lmax
CFP. This normalized spectrum, which corresponds to the ‘‘cross
talk’’, was then subtracted from the extracted acceptor spectrum obtained
in the previous section. This results in an eYFP emission spectrum attrib-
utable solely to FRET.
Measurement of donor/acceptor ratio
The donor/acceptor ratios of the T43NTS1-eCFP/eYFP detergent samples
were calculated by comparing the fluorescence intensity of the maximal
eCFP and eYFP emissions (when excited at lmax
CFP and lmax
YFP, respec-
tively). The fluorescence intensities (F) of eCFP and eYFP were corrected
using the fluorophore quantum yields (F) and the fluorophore molar extinc-
tion coefficients at lmax
CFP and lmax
YFP (3), using Eq. 1 (eCFP,F¼ 0.4, 3¼
29,817 M1cm1 (25–27); eYFP F ¼ 0.61, 3 ¼ 75,768 M1cm1 (27,28)):
F ¼ cFD3: (1)
The donor/acceptor ratios of reconstituted samples were calculated in
a similar manner. However, the calculated donor fluorescence intensity
was corrected using the known FRET signal observed for each sample, to
take into account the decrease in donor emission because of FRET. This
involved summation of the observed eCFP fluorescence with the FRET
emission curve, after correction of the FRET signal to allow for the differ-
ence in extinction coefficient between donor and acceptor, thereby yielding
the eCFP fluorescence intensity in the absence of FRET. This could then be
related directly with the maximal eYFP emission, using Eq. 1.
Calculation of FRET efﬁciency
To allow direct comparison between experiments and with other multimeri-
zation studies of GPCRs in vivo, a parameter termed the ‘‘apparent FRET
efficiency’’ was calculated (17). This does not measure the precise efficiency
of FRET, and is therefore not useful for interfluorophore distance measure-
ments. However, it is a rapid method for the comparison of the relative
ability of GPCRs to engage in FRET. Apparent FRET efficiency was calcu-
lated as follows:
Eapp ¼ F
FRET
DA
FADA
 100; (2)
where Eapp is the apparent FRET efficiency, FDA
FRET is the fluorescence
intensity attributable to FRET, and FDA
A is the fluorescence intensity of
the acceptor when excited at lmax
YFP.
The corrected FRET efficiency was calculated as follows (29,30):
E ¼

3A
3D

FFRETDA
FADA

; (3)Biophysical Journal 96(3) 964–973where E is the corrected FRET efficiency, 3A is the molar extinction
coefficient of eYFP at lmax
YFP (75,768 M1cm1 (27)), and 3D is the molar
extinction coefficient of the donor at lmax
CFP (29,817 M1cm1 (25)). The
corrected FRET efficiency was used to calculate the average interfluoro-
phore distance:
R ¼ Ro

1
E
 1
1
6
; (4)
where R is the average distance between donor and acceptor, and Ro is the
Fo¨rster distance for the eCFP/eYFP FRET pair, which was calculated as
described in the Supporting Material.
Radioligand binding assays
A 3H-NT (New England Nuclear, Perkin Elmer, Waltham, MA) radioligand
binding assay was used to quantify amounts of active receptor present
throughout the purifications. Samples were incubated in assay buffer (50 mM
Tris, pH 7.4, 0.1%DDM (w/v), 0.01%CHS (w/v), 1 mMEDTA, and 0.1mg/
mL bovine serum albumin) containing 3H-NT to a final concentration of 5 nM
(1 h, 4C). Detergent was omitted from the buffer for reconstituted samples.
Nonspecific binding was quantified in the presence of excess unlabeled NT
(3.5mM). Separation of bound from free ligandwas achieved by gel filtration,
using P30Tris spin columns (BioRad) for detergent-solubilized fractions, and
by filtration, using Durapore PVDF membranes with a 0.2-mm molecular
mass cutoff (Millipore, Carrigtwohill, Ireland) for reconstituted samples.
In-gel ﬂuorescence
The fluorescence of eCFP and eYFP moieties was monitored by in-gel fluo-
rescence (31,32), using standard Tris-Glycine SDS PAGE (Invitrogen,
Paisley, UK). The eCFP-His6/eYFP-His6 standards were loaded onto the
same gel, to allow quantification of the amount of fluorescent protein present
in receptor samples. To detect fluorescent bands, the gel was illuminated
with ultraviolet light, and images were captured with a CCD camera system
(Gel Doc, BioRad). Fluorescence intensities were quantified using ImageJ
software version 1.36b (National Institutes of Health, Bethesda, MD), and
the gels were subsequently stained with Coomassie brilliant blue.
RESULTS
Production of NTS1 labeled with ﬂuorescent
proteins
The T43NTS1-eCFP and T43NTS1-eYFP (24) were ex-
pressed in Escherichia coli as the fusion proteins NTS1C
and NTS1Y (Fig. 1 A). After detergent solubilization and
purification by nickel-affinity chromatography, the fusion
proteins were removed, using tobacco etch virus (TeV)
protease cleavage, and the resulting T43NTS1-eCFP and
T43NTS1-eYFP proteins were isolated from the cleavage
products, using gel-filtration chromatography. Purification
was monitored using a radioligand binding assay and in-
gel fluorescence (Fig. 1 B) (32). A typical purification
from 20 g of cell pellet yielded 8.6 5 0.5 nmol (0.6 5
0.04 mg) of cleaved, fluorescence-tagged receptor, as deter-
mined by in-gel fluorescence.
Radioligand binding analysis confirmed the high affinity
of purified fluorescent receptor for NT, both before (Kd ¼
0.55 0.2 nM) and after (Kd ¼ 0.65 0.2 nM) reconstitution
(Fig. 2 A). These affinities compared well with the affinity of
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as the affinities for the NT-NTS1 interaction reported previ-
ously (6,33–35). Saturationbinding experiments for all samples
gave Hill numbers of ~1 (Fig. 2 B), with reconstituted NTS1-
eYFP, detergent-solubilized NTS1-eYFP, and detergent-solu-
bilized NTS1 yielding Hill numbers of 1.25 0.1, 0.85 0.1,
and 1.05 0.1, respectively, indicating that one receptor binds
one ligand molecule with no cooperativity.
NTS1 is monomeric in detergent solution
The FRET experiments were performed on purified, fluores-
cence-tagged receptors in detergent solution. Fig. 3 shows
the emission spectra for the mixed T43NTS1-eCFP and
T43NTS1-eYFP sample (eCFP/eYFP molar ratio of 1:1 5
0.02) excited at 440 nm, and the corresponding subtractions
FIGURE 2 Radioligand ligand-binding data for detergent-solubilized and
reconstituted NTS1: - and solid line, reconstituted NTS1-eYFP;  and
dotted line, detergent-solubilized NTS1-eYFP; : and dashed line, deter-
gent-solubilized NTS1. (A) Saturation binding of tritiated NT to receptor
samples. Data were fitted to Langmuir isotherms to give a measure of
binding affinity. (B) Hill plot for binding data.of ‘‘bleed through’’ and ‘‘cross talk’’ to yield the eYFP emis-
sion attributable to FRET. It is evident from the baseline
emission spectrum after subtraction (Fig. 3) that, at a concen-
tration of 60 nM and a higher concentration of 200 nM, no
FRET occurred. Repetition of the experiment in the presence
of 10 mM agonist (NT) also failed to show any FRET
between eCFP-tagged and eYFP-tagged receptors. These
results together indicate that the interfluorophore distance
between the eCFP and eYFP tags is too large for FRET to
occur (>100 A˚), and therefore the receptor is monomeric
in detergent solution over this concentration range, with no
sample aggregation. In addition, agonist binding does not
trigger multimerization of the detergent-solubilized receptor,
at least within the timescale of the FRET experiment (up to
1 h, 4C).
FIGURE 3 Use of FRET to detect multimerization of purified T43NTS1-
eCFP and T43NTS1-eYFP in detergent solution at concentrations of 60 nM
(A) and 200 nM (B). Samples were excited at lmax
CFP (440 nm), and fluores-
cence emission was detected by scanning fluorometry. Fluorescence emis-
sion attributable to FRET (gray solid line) was determined by subtracting
normalized emission spectrum of a T43NTS1-eCFP sample (black dashed
line) and normalized emission spectrum of a T43NTS1-eYFP sample (black
dotted line) from the emission spectrum of the mixed T43NTS1-eCFP and
T43NTS1-eYFP sample (black solid line).Biophysical Journal 96(3) 964–973
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proteoliposomes
Purified fluorescent receptor was reconstituted into BPL
liposomes, using a strategy based on partial vesicle solubili-
zation (36,37). Detergent was removed by hydrophobic
adsorption, using polystyrene beads (38) and proteolipo-
somes isolated using sucrose density gradient centrifugation
(Fig. 4 A). Analysis of the resulting proteoliposome band by
in-gel fluorescence (Fig. 4 B) and a radioligand binding assay
revealed that the receptor was reconstituted in a conformation
that was both fluorescent and able to bind NT (Kd ¼ 0.65
0.2 nM) (Fig. 2 A), with a recovered receptor yield of
49.6% 5 14.9% in the proteoliposome fraction (relative to
the amount of fluorescent receptor added to the reconstitu-
tion). The in-gel fluorescence analysis (Fig. 4 B) did not
reveal the presence of any free CFP or YFP in the reconsti-
tution samples. Tryptic digestion of the reconstituted recep-
tors and a subsequent densitometry analysis of cleavage
fragments separated by SDS-PAGE and visualized by in-
gel fluorescence suggested that 53%5 2% (n¼ 4) of the re-
constituted receptor was oriented with the ligand-binding site
on the outer face of the proteoliposomes (data not shown).
This suggests that the receptor is inserted into the liposomes
in a random orientation, which was suggested to be a prop-
erty of DDM-mediated reconstitutions of membrane proteins
(39).
The FRET measurements were performed on reconsti-
tuted T43NTS1-eCFP/eYFP samples, both in the absence
and presence of NT. The receptor density was controlled
by varying the initial lipid/protein ratio of reconstitutions
between 6000:1 and 1000:1 (eCFP/eYFP molar ratio of
1:15 0.03). Significant FRET was observed in all samples
(Fig. 5 and Table 1), and was independent of the presence of
FIGURE 4 Reconstitution of fluorescence-tagged NTS1 into BPL vesi-
cles. (A) Sucrose density gradient centrifugation of T43NTS1-eCFP/eYFP
reconstitution samples. Initial lipid/protein ratios were 1000:1 (tube 1) and
2000:1 (tube 2). Proteoliposome bands are indicated by arrows. (B) In-gel
fluorescence analysis of proteoliposome bands harvested from density gradi-
ents. Samples were separated by SDS-PAGE, using a 12% Tris-Glycine gel.
Lane 1, molecular mass marker; lane 2, 1000:1; lane 3, 2000:1. Fluorescent
receptor bands are indicated by arrow.Biophysical Journal 96(3) 964–973NT agonist. In addition, apparent FRET efficiency did not
vary significantly with receptor density, suggesting that the
FRET is caused by a true NTS1-NTS1 interaction in the
membrane. If FRET arises from random collisions, a pseudo-
linear increase in FRET efficiency with receptor density
would be expected, as was reported in BRET studies with
other GPCRs (16,40).
Competition experiments suggest a speciﬁc
receptor-receptor interaction
The measurement of FRET efficiency was performed in
reconstituted samples containing varying amounts of non-
fluorescently tagged receptor. A constant initial molar ratio
of lipid/fluorescent protein was used for each reconstitution
(6000:1). Only the amount of untagged NTS1 receptor was
varied, thereby maintaining, as far as possible, a constant
density of fluorescent receptor in themembrane. The apparent
FRET efficiency decreased linearly with an increasing molar
percentage of untagged receptor (Fig. 6). This is indicative of
a specific receptor-receptor interaction, rather than bystander
FRET, and the linear relationship supports the suggestion
of an NTS1 homodimer, because deviation from linearity
would be expected for higher-order multimers or aggregates
(41). In addition, this result rules out the possibility that
the observedmultimerization of fluorophore-tagged receptors
is driven by interactions between eCFP/eYFP fluorescent
proteins, which were previously shown to dimerize at high
concentrations (42).
NTS1 forms a homodimer in reconstituted
membranes
Further experiments, designed to elucidate the precise multi-
merization state of the receptor, were performed. The donor
(eCFP)/acceptor (eYFP) ratio was varied by adding purified
eCFP-tagged and eYFP-tagged receptor to the reconstitu-
tions in the desired proportions. The ratio was confirmed
using fluorescence intensity measurements of the donor
and acceptor after reconstitution. Control of the donor/
acceptor ratio is essential for a correct quantitative analysis
of FRET efficiency. Care was taken to keep the overall fluo-
rescent receptor density constant for each sample (initial
lipid/protein molar ratio of 6000:1), thereby removing inter-
pretation complications that could arise from potential
bystander FRET, which would vary pseudolinearly with
receptor density (16,43).
Apparent FRET efficiency decreased as the proportion of
NTS1-eYFP, expressed as a percentage of total fluorescent
receptor, increased (Fig. 7 A). This result is to be expected
for a multimeric interaction, because an increased proportion
of acceptor increases the likelihood that an acceptor monomer
will be in a multimeric complex containing no donor fluoro-
phores (and hence will not be amenable to FRET) (Fig. 7 B).
Such a relationship should not be observed if FRET is caused
Dimerization of NTS1 969FIGURE 5 Use of FRET to detect
multimerization of lipid-reconstituted
T43NTS1-eCFP/eYFP at varied receptor
densities. Reconstitution samples had
starting lipid/protein ratios of 1000:1
(A), 2000:1 (B), 4000:1 (C), and
6000:1 (D). Samples were excited at
lmax
CFP (440 nm), and fluorescence
emission was detected by scanning flu-
orometry. Fluorescence emission attrib-
utable to FRET (gray solid line) was
determined by subtracting normalized
emission spectrum of a T43NTS1-
eCFP-only sample (black dashed line)
and normalized emission spectrum of
a T43NTS1-eYFP-only sample (black
dotted line) from emission spectrum of
the mixed T43NTS1-eCFP and
T43NTS1-eYFP sample (black solid
line).by random collisions, provided that (as is the case here) the
total receptor density is kept constant (16).
To distinguish between dimers and higher-order oligo-
mers, the experimental results were compared with modeled
FRET curves, derived using an equation that describes the
probability of forming FRET-competent complexes as
a function of the number of receptors within a complex
(40,44,45). The experimental data fit closely to the model
curve for the dimer (Fig. 7 C), suggesting that the average
stoichiometry of NTS1 in the reconstituted membranes is
a dimer. Assuming that the receptor exists in equilibrium
between monomer and dimer, it is possible to estimate the
proportion of receptor that exists in a multimeric versus
monomeric conformation. The equation presented in the
legend of Fig. 7 can be modified to account for a dimeric
receptor with a proportion of monomeric population (Sup-
porting Material). Fitting of the modified equation to the
experimental data presented in Fig. 7 A suggests that
TABLE 1 Apparent FRET efﬁciency of T43NTS1-eCFP/eYFP
reconstituted samples in the presence and absence of 50 mMNT
Initial lipid/protein ratio
Apparent FRET efficiency (%)
No NT NT (50 mM)
1000 10.4 10.3
2000 12.0 11.3
4000 11.4 11.5
6000 11.6 11.6
Mean (5 error) 11.45 0.3 11.25 0.3
Apparent FRET efficiency was calculated from emission spectra: ((inte-
grated FRET curve)/(integrated emission curve obtained on direct excitation
of eYFP at lmax
YFP))  100.88.7% 5 0.2% of the reconstituted receptor molecules are
in dimeric form at this receptor density.
DISCUSSION
This study demonstrates that FRET measurements can be
applied successfully to the study of the multimerization state
of GPCRs reconstituted into model lipid membrane systems.
The FRET analysis of eCFP-tagged and eYFP-tagged recep-
tors in detergent solution suggests that NTS1 is monomeric
at receptor concentrations of up to 200 nM. This is in agree-
ment with a previous study of NTS1, which suggested that
although NTS1 can dimerize in detergent solution, such
dimerization is inhibited by the relatively high concentra-
tions of detergent used in the purification procedure (20). It
is therefore possible that decreased detergent concentrations
or increased receptor concentrations could drive the dimer-
ization reaction in detergent solution.
In contrast, the results of FRET experiments with lipid-re-
constituted NTS1 demonstrate constitutive NTS1 multimeri-
zation at receptor densities comparable to recent in vivo RET
studies of GPCR multimerization (16,40). Rigorous control
experiments involving the variation of receptor density, vari-
ation of donor/acceptor ratio, and competition with untagged
receptor were reported as essential for the verification of the
presence of true receptor multimers in RET studies (16).
Here, in the first (to our knowledge) comprehensive applica-
tion of these controls to a RET study of a GPCR in an in vitro
system, we confirmed that FRET arose from a true receptor-
receptor interaction between NTS1 monomers, rather than
from random receptor collisions in the membrane or from
multimerization mediated by dimerization of eCFP/eYFPBiophysical Journal 96(3) 964–973
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tagged NTS1 in the presence of untagged NTS1. (A) Samples were excited
at lmax
CFP (440 nm), and fluorescence emission was detected by scanning
fluorometry. Samples contained 0%, 25%, 50%, 67%, and 80% untagged
NTS1 (dark to light traces). The lipid/fluorescent receptor ratio for each
reconstitution was kept constant. (B) Increasing molar percentage of
untagged receptor caused a decrease in apparent FRET efficiency, which
was fitted linearly (black line). From the fit, a sample containing 100%
untagged receptor would yield a FRET efficiency of 0.6%. This represents
the ‘‘bystander FRET’’ caused by random collisions at this density of fluo-Biophysical Journal 96(3) 964–973fluorescent proteins. A comparison with theoretical calcula-
tions showed that a homodimer model, rather than models
for higher-order interactions or aggregation artifacts, best
fits the experimental data. This result is in agreement with
a previous suggestion that constitutive dimerization is a prop-
erty shared by many (though not all) GPCRs of the Family A
subtype (7–9).
The final lipid/protein molar ratios of proteoliposome
samples were estimated from the isopyknic position on
sucrose gradients (see the Supporting Material). The lipid/
protein molar ratios were significantly lower than the starting
ratios (between 576.45 27.0 for the 1000:1 initial ratio, and
1033.3 5 88.8 for the 6000:1 initial ratio). A similar result
was evident for the detergent-mediated reconstitution of
rhodopsin into asolectin liposomes, where an initial lipid/
protein molar ratio of 10,000:1 resulted in a final ratio of
1000:1 after reconstitution (21). The authors attributed this
phenomenon to the observation that 90% of the rhodopsin
receptors inserted into only 10% of the available liposomes.
In addition, Biobeads have been shown to adsorb small
amounts of lipid during detergent removal (38), which could
also be a contributory factor.
Despite the decrease in lipid/protein ratio during the
reconstitution, the final receptor densities in the reconstituted
samples were low, relative to previous RET studies of
GPCRs. The receptor densities in T43NTS1-eCFP/eYFP
reconstituted samples were calculated from the lipid/protein
molar ratio to be between 0.13 (6000:1 initial) and 0.24
(1000:1 initial) receptors per 10,000 A˚2. In a previous
in vivo study of the b-adrenergic-receptor GPCR fused
with luciferase and green fluorescent protein (GFP) (40),
constant BRET efficiency was observed at expression levels
between 1.4–26 pmol/mg of membrane protein, indicating
a true receptor-receptor interaction and low bystander
BRET. An increase of the expression level to 47 pmol/mg
(2.4 receptor molecules per 10,000 A˚2) and higher gave
a large increase in BRET efficiency, attributed to bystander
BRET. This receptor density is ~10-fold higher than calcu-
lated for the NTS1 reconstituted samples, suggesting that
little contribution from bystander FRET should be expected
in reconstituted samples, supporting the conclusion that
a true multimeric receptor complex is forming.
The apparent efficiency of FRET at a donor/acceptor ratio
of 1:1 (11.2% 5 0.3% and 11.4% 5 0.3% in the absence
and presence of NT, respectively) compares favorably with
the efficiency observed for FRET between eCFP-tagged and
eYFP-tagged yeast a-factor receptor in vivo (11.5% 5
2.2%), a GPCR that is widely believed to dimerize
rescent receptor. (C) Alternative representation of results. F, apparent FRET
efficiency with bystander FRET subtracted. Fo¼ F in the absence of compet-
itor. Data were fitted linearly (black line). The theoretical competition curve
for an NTS1 homodimer is also shown (dotted line). Deviation from linearity
would be expected for higher-order multimers.
Dimerization of NTS1 971constitutively (17). A comparable FRET efficiency was
observed for eCFP-tagged and eYFP-tagged C5a receptor
in vivo (12.6% 5 3.0%) (46). To calculate the precise effi-
FIGURE 7 FRET analysis of NTS1-eCFP/eYFP reconstituted into BPL
liposomes at varying donor/acceptor ratios. (A) Apparent FRET efficiency
is plotted versus percentage of total receptor, which is acceptor-tagged.
Overall receptor densitywas kept constant (6000:1 starting lipid/protein ratio,
confirmed by identical densities on sucrose gradients). The y intercept gives
a measure of Fmax, the FRET that would be observed in the presence of a vast
excess of donor fluorophore (23.2% 5 0.4%). (B) Schematic depiction of
likelihood of tagged receptors forming FRET-competent complexes as
donor/acceptor (d:a) ratio is varied (, acceptors;B, donors). (C) Comparison
of experimental data (solid squares) with theoretical curves for the dimer
(dashed line), trimer (dotted line), and tetramer (solid line). Theoretical
curves are based on the probability that an eYFP-tagged receptor is in
a complex with one or more eCFP-tagged receptors (and hence in a FRET-
capable complex): [(a þ d)n  an  dn]/[(a þ d)n  an  dn þ nan], where
n is the number of receptor molecules in the complex, and a and d are relative
concentrations of acceptor and donor, respectively (40,44,45).ciency of FRET, which in turn allows the quantification of
interfluorophore distance, a ‘‘corrected FRET efficiency’’
term can be calculated. This is a modification of the apparent
FRET efficiency, to take into account the different extinction
coefficients of the donor and acceptor fluorophores at their
respective lmax excitations (Eq. 4). In the presence of
a vast excess of donor fluorophore, the apparent FRET
efficiency (Fmax) was determined to be 23.2% 5 0.4%
(Fig. 7 A). This corresponds to a corrected FRET efficiency
of 59.1%5 1.0%, and an average interfluorophore distance
of 42.95 0.8 A˚. This distance is similar to that derived from
recent atomic-force microscopy studies on rhodopsin from
mouse rod outer segments, which showed rhodopsin orga-
nized within paracrystalline arrays with densely packed,
double rows of receptor (47). Models of atomic-force
microscopy images revealed contact dimers with an intradi-
meric monomer-monomer distance of 38 A˚, and a distance of
46 A˚ between the nearest neighbors from different double
rows (47–49).
The role of a constitutive GPCR dimer as the functional
signaling unit is yet to be demonstrated conclusively,
although it is thought to have important functional implica-
tions, including cell-surface expression, ligand binding,
signaling, and receptor trafficking (8). The saturation binding
data for NTS1 in detergent solution and in lipid bilayers
revealed no evidence of cooperative binding (Fig. 2 B) or
any difference in binding affinity for the NT-NTS1 interac-
tion. Therefore, it appears that dimerization does not serve
to modulate the mechanism of NT binding, at least in the
absence of other cellular components. This result is in agree-
ment with previous binding data for the NT-NTS1 interaction
in themembrane environment, including synapticmembranes
(34) and cell lines (6,35) that did not reveal any cooperativity.
However, our result is in contradiction with a previous study
of NTS1 in detergent solution (20), which suggested that
cooperative binding was driven by the monomer-dimer tran-
sition. In addition, the minimal unit for GPCR function is still
debated. In the case of rhodopsin, the existence of dimers
in vivo is still questioned (50), with separate studies support-
ing either one (49) or two (51) G-protein heterotrimers per
receptor dimer. The demonstration that single b-adrenergic-
receptor monomers, reconstituted into high-density lipopro-
tein phospholipid bilayer particles, can efficiently activate
heterotrimeric G-proteins suggests that the GPCR monomer
is the minimal functional unit necessary for signaling in this
case (52). In contrast, the leukotriene B4 receptor, another
GPCR of the family A subtype that dimerizes and forms a het-
eropentameric complex with a single G-protein heterotrimer
(11), was shown to demonstrate full G-protein activation
when only a single subunit of the dimer was occupied with
an agonist (53).
The reconstitution of purified T43NTS1-eCFP/eYFP into
BPL vesicles appears to provide a useful minimal, in vitro
experimental system for the study of NTS1 multimerization.
Increasing the complexity of the system through the additionBiophysical Journal 96(3) 964–973
972 Harding et al.of other signaling components could be envisaged in a quanti-
tative, controlled manner. In addition, our results demonstrate
the potential of the system in the study of the dimerization
interface, the location and specificity of which are still contro-
versial topics in theGPCRfield (8). The importance of specific
lipids is also emphasized, both in the maintenance of a ligand-
binding conformation ofNTS1 and inmultimerization interac-
tions. This approach could provide useful insights into the
multimerization states of other GPCRs for which expression
and purification protocols can be established.
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